Literature DB >> 7340908

The genital Mycoplasma and Ureaplasma flora of healthy and diseased dogs.

P A Doig, H L Ruhnke, W T Bosu.   

Abstract

The genital mycoplasma and ureaplasma flora was compared in 136 dogs with varied reproductive histories. Mycoplasmas were recovered from 88% of vulvovaginal swabs, 85% preputial swabs and 72% semen samples. Isolation rates were slightly higher from dogs that were infertile or had evidence of genital disease but the differences from those that were fertile or clinically normal were statistically significant only in the male. Ureaplasmas were recovered from half the females sampled. Higher, but not statistically significant isolation rates (75%) were made from infertile females with purulent vulvar discharge versus those that were clinically normal and fertile (40%). In the male dog there was a significantly higher incidence of ureaplasmas in the prepuce of infertile animals (69%) than those that were fertile (0%) (p less than or equal to 0.05). Semen isolations although not significantly higher in infertile males, were all made from ejaculates, with subnormal motility, low sperm counts and/or a high percentage of midpiece and tail abnormalities (bent or tightly coiled).

Entities:  

Mesh:

Year:  1981        PMID: 7340908      PMCID: PMC1320213     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  9 in total

1.  The isolation of organisms of the pleuropneumonia group from dogs.

Authors:  D G EDWARD; W A FITZGERALD
Journal:  J Gen Microbiol       Date:  1951-08

2.  Isolation and serological grouping of ureaplasmas from dogs.

Authors:  H Kotani; M Ogata
Journal:  Nihon Juigaku Zasshi       Date:  1979-12

3.  Isolation of T-mycoplasmas from dogs and squirrel monkeys: biological and serological comparison with those isolated from man and cattle.

Authors:  D Taylor-Robinson; C Martin-Bourgon; T Watanabe; J P Addey
Journal:  J Gen Microbiol       Date:  1971-09

4.  Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material.

Authors:  M C Shepard; C D Lunceford
Journal:  J Clin Microbiol       Date:  1976-06       Impact factor: 5.948

5.  Isolation of Ureaplasma from bovine granular vulvitis.

Authors:  H L Ruhnke; P A Doig; A L MacKay; A Gagnon; M Kierstead
Journal:  Can J Comp Med       Date:  1978-04

6.  Bovine granular vulvitis associated with ureaplasma infection.

Authors:  P A Doig; H L Ruhnke; A L MacKay; N C Palmer
Journal:  Can Vet J       Date:  1979-04       Impact factor: 1.008

7.  Experimental bovine genital ureaplasmosis. I. Granular vulvitis following vulvar inoculation.

Authors:  P A Doig; H L Ruhnke; N C Palmer
Journal:  Can J Comp Med       Date:  1980-07

8.  Experimental bovine genital ureaplasmosis. II. Granular vulvitis, endometritis and salpingitis following uterine inoculation.

Authors:  P A Doig; H L Ruhnke; N C Palmer
Journal:  Can J Comp Med       Date:  1980-07

9.  Isolation of mycoplasmas from the canine genital tract: a survey of 108 healthy dogs.

Authors:  A Bruchim; I Lutsky; S Rosendal
Journal:  Res Vet Sci       Date:  1978-09       Impact factor: 2.534

  9 in total
  4 in total

1.  Genital mycoplasmas of healthy bitches.

Authors:  Zinka Maksimović; Alan Maksimović; Anis Halilbašić; Maid Rifatbegović
Journal:  J Vet Diagn Invest       Date:  2018-05-23       Impact factor: 1.279

2.  Aerobic bacteria occurring in the vagina of bitches with reproductive disorders.

Authors:  L Bjurström
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

3.  Effect of sterilization on the canine vaginal microbiota: a pilot study.

Authors:  Ada Rota; Michela Corrò; Ilaria Patuzzi; Chiara Milani; Stefania Masia; Eleonora Mastrorilli; Sara Petrin; Alessandra Longo; Angela Del Carro; Carmen Losasso
Journal:  BMC Vet Res       Date:  2020-11-23       Impact factor: 2.741

Review 4.  Infectious causes of embryonic and fetal mortality.

Authors:  M Daniel Givens; M S D Marley
Journal:  Theriogenology       Date:  2008-05-27       Impact factor: 2.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.